| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $68.0M | +10.9% | +49.5% |
| Cost of Revenue | $23.0M | +9.0% | +35.4% |
| Gross Profit | $45.1M | +11.8% | +57.8% |
| R&D Expense | $10.3M | +2.8% | +16.4% |
| SG&A Expense | $14.3M | +16.5% | +34.5% |
| Operating Income | -$2.5M | +42.2% | +70.5% |
| Pre-tax Income | -$3.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $198.6M | -11.0% | — |
| Accounts Receivable | $41.4M | +24.5% | — |
| Inventory | $3.1M | -9.3% | — |
| Current Assets | $254.9M | -6.0% | — |
| Total Assets | $287.5M | -5.1% | — |
| Current Liabilities | $70.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.1M | — | — |
| Capital Expenditures | $1.1M | — | — |
| Investing Cash Flow | -$4.5M | — | — |
| Financing Cash Flow | $129.8M | — | — |
| Free Cash Flow | -$4.3M | — | — |
| +40.2% |
| +65.6% |
| Income Tax | $0 | — | — |
| Net Income | -$3.2M | +40.2% | +65.6% |
| EPS (Basic) | -$0.06 | +75.0% | +94.9% |
| EPS (Diluted) | -$0.06 | +75.0% | +94.9% |
| +20.9% |
| — |
| Long-term Debt | $0 | -100.0% | — |
| Total Liabilities | $70.1M | -21.0% | — |
| Stockholders' Equity | $217.3M | +1.5% | +157.2% |